211At-Methylene Blue for Targeted Radiotherapy of Human Melanoma Xenografts: Treatment of Micrometastases

Cancer Research

Volumn 50, Issue 10, 1990, Pages 2963-2967

  Link, Eva M ^a   Carpenter, Robert N ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASTATINE; METHYLENE BLUE; ASTATINE 211; RADIOISOTOPE;

ANIMAL; ARTICLE; BRACHYTHERAPY; CANCER TRANSPLANTATION; EMBOLISM; HUMAN; LUNG CIRCULATION; MELANOMA; METASTASIS; MOUSE; NUDE MOUSE; TIME; ANIMAL EXPERIMENT; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LUNG; NONHUMAN; PRIORITY JOURNAL; RADIOTHERAPY; TUMOR XENOGRAFT;

ANIMAL; ASTATINE; BRACHYTHERAPY; EMBOLISM; HUMAN; MELANOMA; METHYLENE BLUE; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PULMONARY CIRCULATION; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0025195082     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Paneth, F., and Hevesy, G. Über Radioelemente als Indikatoren in der Analytischen Chemie. Monatschr. Chem., 34:1401–1407, 1913.
2. Hevesy, G. The absorption and translation of lead by plants. A contribution to the application of the method of radioactive indicators in the investigation of the change of substance in plants. Biochem. J., 77:439–445, 1923.
3. Blumgart, H. L., and Yens, O. C. Studies on velocity of blood flow; the method utilized. J. Clin. Invest., 4: 1–13, 1927.
4. Chievitz, O., and Hevesy, G. Studies on the metabolism of phosphorus in animals. KGL Danske Videnskabernes Selskab. Biol. Meddelelser, 13:9–33, 1937.
5. Lawrence, J. H., Scott, K. G., and Tuttle, L. W. Studies on leukemia with aid of radioactive phosphorus. Intern. Clin., 3:33–58, 1939.
6. Hertz, S., Roberts, A., and Evans, R. D. Radioactive iodine as indicator in study of thyroid physiology. Proc. Soc. Exp. Biol. Med., 38: 510–513, 1938.
7. Hamilton, J. G., and Soley, M. H. Studies in iodine metabolism of the thyroid gland in situ by the use of radio-iodine in normal subjects and in patients with various types of goiter. Am. J. Physiol., 131: 135–143, 1940.
8. Mitchell, J. S. Attempts to develop radioactive drugs in the treatment of cancer. In: Radiotracer Techniques and Applications, 2:1081–1109, 1977.
9. Potts, A. M. Uveal pigment and phenothiazine compounds. Trans. Am. Ophthalmol. Soc., 60: 517–552, 1962.
10. Link, E. M., and Lukiewicz, S. A new radioactive drug selectively accumulating in melanoma cells. Eur. J. Nucl. Med., 7:469–473, 1982.
11. Link, E. M., Brown, I., Carpenter, R. N., and Mitchell, J. S. Uptake and therapeutic effectiveness of, 125I- and 211 At-methylene blue for pigmented melanoma in an animal model system. Cancer Res., 49:4332–4337, 1989.
12. Link, E. M., and Rydzy, M. Endoirradiation of neoplastic tissues by administered radioisotopes. In: Proceedings of the Third Meeting of the Polish Biophysics Society, p. 62, 1978.
13. Brown, J. M., Twentyman, P. R., and Zamvil, S. S. Response of the RIF-1 tumour in vitro and in C3H/Km mice to X-radiation (cell survival, regrowth delay and tumour control), chemotherapeutic agents, and activated macrophages. J. Natl. Cancer Inst., 64:605–611, 1980.
14. West, C. M. L., Sandhu, R. R., and Stratford, I. J. The radiation response of V79 and human tumour multicellular spheroids–cell survival and growth delay studies. Br. J. Cancer, 50: 143–151, 1984.
15. Brown, I., Carpenter, R. N., Link, E. M., and Mitchell, J. S. Potential diagnostic and therapeutic agents for malignant melanoma: synthesis of heavy radiohalogenated derivatives of methylene blue by electrophilic and nucleo-philic methods. J. Radioanal. Nucl. Chem. Lett., 107: 337–351, 1986.